ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VERU Veru Inc

1.48
0.13 (9.63%)
May 01 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Veru Inc VERU NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.13 9.63% 1.48 18:57:12
Open Price Low Price High Price Close Price Previous Close
1.38 1.35 1.49 1.49 1.35
more quote information »

Recent News

Date Time Source Heading
5/01/202407:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
4/30/202407:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
4/25/202407:30GLOBEVeru to Present at the American Association of Clinical..
4/01/202415:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
3/22/202415:05GLOBEVeru Reschedules Annual Meeting of Shareholders
3/12/202407:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
2/27/202418:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
2/20/202407:30GLOBEVeru Announces New Scientific Advisory Board for its..
2/15/202415:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2/15/202415:06EDGAR2Form 8-K - Current report
2/14/202415:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202406:00EDGAR2Form 8-K - Current report
2/08/202405:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
2/06/202415:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202407:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
1/31/202407:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
1/26/202415:06EDGAR2Form 8-K - Current report
1/26/202408:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/26/202408:00EDGAR2Form DEF 14A - Other definitive proxy statements
1/25/202407:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
1/08/202407:30GLOBEVeru Submits IND Application to FDA for the Development of..
12/26/202315:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/19/202307:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
12/18/202308:01EDGAR2Form 8-K - Current report
12/15/202315:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/14/202308:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
12/13/202315:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/13/202315:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/13/202315:04EDGAR2Form 8-K - Current report
12/13/202315:01GLOBEVeru Announces Proposed Public Offering of Common Stock
12/08/202315:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/08/202313:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/17/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202315:54EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
11/15/202315:50EDGAR2Form 8-K - Current report
10/04/202307:30GLOBEVeru Reports Muscle Data from 5 Clinical Studies of..
10/02/202316:23EDGAR2Form 8-K - Current report
9/28/202315:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
9/26/202307:30GLOBEVeru Reaches Agreement with FDA on New Phase 3 Clinical..
9/20/202307:30GLOBEVeru to Participate in Fireside Chat at the 2023 Cantor..
9/11/202306:00EDGAR2Form 8-K - Current report
9/11/202306:00GLOBEVeru Reports Clinical Data from the Discontinued ARTEST..
8/30/202307:30GLOBEVeru to Present at the H.C. Wainwright 25th Annual Global..
8/10/202311:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202306:00EDGAR2Form 8-K - Current report
8/10/202305:30GLOBEVeru Reports Fiscal 2023 Third Quarter Financial Results
8/03/202307:30GLOBEVeru to Report Fiscal 2023 Third Quarter Financial Results..

Your Recent History

Delayed Upgrade Clock